Effectiveness of a cephalosporin, cefotetan, in inhibition of uterine matrix metalloproteinases by a non-antibacterial mechanism.
Scarpellini
F
F
II Department of Obstetrics/Gynecology, University La Sapienza, Rome, Italy.
Scarpellini
L
L
Sbracia
M
M
Curto
C
C
D015415:Biomarkers / Q000097:blood / Q000652:urine; D018394:CA-125 Antigen / Q000097:blood; D015313:Cefotetan / Q000627:therapeutic use*; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000188:drug therapy* / Q000503:physiopathology; D005353:Fibronectins / Q000097:blood; D006025:Glycosaminoglycans / Q000652:urine; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors*; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D012312:Ritodrine / Q000627:therapeutic use*; D014599:Uterus / Q000201:enzymology*; D000515:alpha 1-Antitrypsin / Q000032:analysis
D015415:Biomarkers; D018394:CA-125 Antigen; D005353:Fibronectins; D006025:Glycosaminoglycans; D000515:alpha 1-Antitrypsin; D015313:Cefotetan; D008666:Metalloendopeptidases; D012312:Ritodrine; D006909:Hydroxyproline